A perspective on the American Heart Association/American College of Cardiology science advisory on thiazolidinedione drugs and cardiovascular risks.
作者信息
Krumholz Harlan M
出版信息
Circ Cardiovasc Qual Outcomes. 2010 May;3(3):221-2. doi: 10.1161/CIRCOUTCOMES.110.936070. Epub 2010 Feb 24.
Abstract
摘要
相似文献
1
A perspective on the American Heart Association/American College of Cardiology science advisory on thiazolidinedione drugs and cardiovascular risks.
Circ Cardiovasc Qual Outcomes. 2010 May;3(3):221-2. doi: 10.1161/CIRCOUTCOMES.110.936070. Epub 2010 Feb 24.
2
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation.噻唑烷二酮类药物与心血管风险：美国心脏协会和美国心脏病学基金会的科学咨询意见
Circulation. 2010 Apr 27;121(16):1868-77. doi: 10.1161/CIR.0b013e3181d34114. Epub 2010 Feb 23.
3
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation.噻唑烷二酮类药物与心血管风险：美国心脏协会和美国心脏病学会基金会的科学咨询意见
J Am Coll Cardiol. 2010 Apr 27;55(17):1885-94. doi: 10.1016/j.jacc.2010.02.014.
4
[The effects of thiazolidinedione from the cardiologic viewpoint].[从心脏病学角度看噻唑烷二酮类药物的作用]
Med Monatsschr Pharm. 2005 Oct;28(10):365.
5
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.噻唑烷二酮类药物的使用、液体潴留与充血性心力衰竭：美国心脏协会和美国糖尿病协会的共识声明。2003年10月7日。
Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E.
6
Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.专家组建议放宽对罗格列酮的限制，尽管存在心血管安全性方面的担忧。
JAMA. 2013 Jul 17;310(3):246-7. doi: 10.1001/jama.2013.8141.
7
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?噻唑烷二酮类药物在 2 型糖尿病治疗中仍有作用吗？
Diabetes Obes Metab. 2013 Nov;15(11):967-77. doi: 10.1111/dom.12101. Epub 2013 Apr 18.
8
Revisiting the rosiglitazone story--lessons learned.重温罗格列酮事件——汲取的教训。
N Engl J Med. 2010 Aug 26;363(9):803-6. doi: 10.1056/NEJMp1008233. Epub 2010 Jul 21.
9
[Too positive comment on glitazones].[对格列酮类药物的过度正面评价]
Ugeskr Laeger. 2007 Feb 19;169(8):733; author reply 733.
10
The Yin and the Yang of CV risks in patients with diabetes.糖尿病患者心血管风险的阴阳两面。
Am J Manag Care. 2014 May;20(8 Spec No.):E6.
Zotero 插件